Invitrogen Bioservices India Profile
Key Indicators
- Authorised Capital ₹ 3.00 Cr
- Paid Up Capital ₹ 1.38 Cr
- Company Age 20 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Revenue Growth -28.08%
- Profit Growth -55.24%
- Ebitda -50.71%
- Net Worth 55.75%
- Total Assets -1.44%
About Invitrogen Bioservices India
Invitrogen Bioservices India Private Limited (IBIPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 28 December 2004 and has a history of 20 years and one month. Its registered office is in Bangaluru, Karnataka, India.
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 1.38 Cr, as per Ministry of Corporate Affairs (MCA) records.
Nagabushana Reddy, Dinesh Palanivelu, and Vikram Kulkarni serve as directors at the Company.
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U73100KA2004PTC035330
- Company No.
035330
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Dec 2004
- Date of AGM
26 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Invitrogen Bioservices India?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nagabushana Reddy  | Director | 15-Sep-2014 | Current |
| Dinesh Palanivelu | Whole-Time Director | 08-Dec-2022 | Current |
| Vikram Kulkarni | Whole-Time Director | 23-Feb-2022 | Current |
Financial Performance of Invitrogen Bioservices India.
Invitrogen Bioservices India Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 28.08% decrease. The company also saw a substantial fall in profitability, with a 55.24% decrease in profit. The company's net worth Soared by an impressive increase of 55.75%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Invitrogen Bioservices India?
In 2023, Invitrogen Bioservices India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Smashclaycourt Academy LlpDinesh Palanivelu is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Invitrogen Bioservices India?
Unlock and access historical data on people associated with Invitrogen Bioservices India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Invitrogen Bioservices India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Invitrogen Bioservices India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
